During the past decade, Ankara Numune Training and Research Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ankara Numune Training and Research Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Ankara City Hospital Bilkent" with 1 trials sponsored, "Ankara Education and Research Hospital" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Ege University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara Numune Training and Research Hospital" #1 collaborator was "Abant Izzet Baysal University" with 1 trials as a collaborator, "Ankara City Hospital Bilkent" with 1 trials as a collaborator, "Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Private Gozde Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ankara Numune Training and Research Hospital" are "Anxiety" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Ectasia" (1 trials), "Cushing's Syndrome" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "Ankara Numune Training and Research Hospital" in a lesser frequency.

Most popular intervention types in "Ankara Numune Training and Research Hospital" are "Drug" (4 trials), "Procedure" (3 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban 2.5 mg" (1 trials), "Apixaban placebo" (1 trials), "Epacadostat" (1 trials), "Glutamine" (1 trials) and "JNJ-64179375 (Dose to be Determined)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ankara Numune Training and Research Hospital" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ankara Numune Training and Research Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ankara Numune Training and Research Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ankara Numune Training and Research Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".